ArticleCardio-oncology (London, England)2026
Rapid symptomatic and metabolic response to emergency radiotherapy in a critically ill patient with primary cardiac lymphoma: a multidisciplinary case report.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Primary cardiac lymphoma (PCL), an exceptionally rare and aggressive malignancy with median survival under one month, often presents with contraindications to first-line chemotherapy in critically ill patients. We report a 66-year-old woman with acute heart failure, pulmonary embolism, and ECOG performance status 4, diagnosed with right atrial diffuse large B-cell lymphoma (76 × 75 mm, SUVmax = 29.1). Due to chemotherapy contraindications, emergency radiotherapy (18 Gy/10 fractions) was initiated. Within five fractions, significant symptomatic improvement occurred with resolution of dyspnea and edema, accompanied by improved oxygenation (SpO₂ 86%→95%) and ECOG status (4→3). Post-treatment PET/CT demonstrated a profound metabolic response (SUVmax = 2.9-3.6), enabling successful transition to systemic chemotherapy. This case underscores emergency radiotherapy as an effective bridge therapy for critically ill PCL patients, facilitated by multidisciplinary coordination.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.